Treatment of Gaucher's disease with OGT 918
- 1 August 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 356 (9230) , 676-7
- https://doi.org/10.1016/s0140-6736(00)02618-0
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesisThe Lancet, 2000
- Enzyme therapy for Gaucher disease: the first 5 yearsBlood Reviews, 1998
- Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N -ButyldeoxynojirimycinScience, 1997